Abstract
Fungal immunomodulators are high-value compounds in nutraceuticals and the high-value pharmaceutical market. Fungal immunosuppressors such as cyclosporins, mycophenolic acid and their derivatives are important medicines for the treatment of many diseases; and they are widely used as the main therapy for pre- and post-organ transplantation treatments to minimize the risk of the body’s rejection of the xenotransplanted organ. Further, fungal immunostimulators have a long history in nutraceuticals and preventive medicine through stimulation of the body defense mechanisms. However, most of the known immunostimulators were obtained from macrofungi (mushrooms). More recently, many fungal immunostimulators were used effectively to prevent and to treat many types of cancer. Thus, both the roles of immunosuppressor and immunostimulator are equally important. This chapter provides recent information regarding the chemistry, biosynthesis and industrial production of different types of fungal immunomodulators.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aarnio TH, Agathos SN (1990) Pigmented variants of Tolypocladium inflatum in relation to cyclosporine A production. Appl Microbiol Biotechnol 33:435--437
Abdel Fattah YR, El Enshasy H, Anwar M, Omar H, Abou El Magd E, Abou Zahra R (2007) Application of factorial experimental designs for optimization of cyclosporine A production by Tolypocladium inflatum in submerged culture. J Microbiol Biotechnol 17:1930–1936
Abraham EP (1945) The effect of mycophenolic acid on the growth of Staphylococcus aureus in heart broth. Biochem J 39:398–404
Adachi K, Chiba K (2007) FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology. Perspect Med Chem 1:11–23
Adachi K, Kohara T, Nakao N, Arita M, Chiba K, Mishina T, Sasaki S, Fujita T (1995) Design, synthesis, and structure–activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720. Med Chem Lett 5:853–856
Adachi Y, Ohno N, Ohsawa M, Oikawa S, Yadomae T (1990) Change of biological activities of (1→3)-β-D-glucan from Grifola frondosa upon molecular-weight reduction by heat-treatment. Chem Pharmaceut Bull 38:477–481
Agathos SN, Lee J (1993) Mathematical modeling of the production of cyclosporine A by Tolypocladium inflatum: Effect of L-valine. Biotechnol Prog 9:54–63
Agathos SN, Marshall JW, Moraiti C, Parekh R, Madhosingh C (1986) Physiological and genetic factors for process development of cyclosporine fermentations. J Ind Microbiol 1:39–48
Agawal SS, Singh VK (1999) Immunomodulators: A Review of Studies on Indian Medicinal Plants and Synthetic Peptides. Proc Ind Natl Sci Acad B65:179–204
Alani F, Grove J, Anderson WA, Moo-Young M (2009) Mycophenolic acid production in solid-state fermentation using a packed-bed bioreactor. Biochem Eng J 44:105–110
Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85–118
Alloway RR (1999) Generic immunosuppressant use in solid organ transplantation. Transplant Proc 31[Suppl 3A]:2S–5S
Alsberg CL, Black OF (1913) Contribution of the study of maize deterioration; biochemical and toxicological investigations of Penicillium puberulum and Penicillium stolonigerum. Bull Burl Anim Ind US Dept Agric 270:1–47
Amano S, Ogawa N, Ohtsuka M, Ogawa S, Chida N (1998) Total synthesis and absolute configuration of FR65814. Chem Commun 1263–1264
Amano S, Ogawa N, Ohtsuka M, Chida N (1999) Chiral and stereoselective total synthesis of novel immunosuppressant FR65814 from D-glucose. Tetrahedron 55:2205–2224
Anderson WK, Boehm TL, Makara GM, Swann TR (1996) Synthesis and modeling studies with monocyclic analogues of mycophenolic acid. J Med Chem 39:46–55
Ando K, Suzuki S, Tamaura G, Arima K (1968) Antiviral activity of mycophenolic acid. Studies on antiviral and antitumor antibiotic IV. J Antibiot 21:649–652
Appel GB, Radhakrishnan J, Ginzler EM (2005) Use of mycophenolate mofetil in autoimmune and renal diseases. Transplantation 80[Suppl]: S265–S271
Aw MM, Verma A, Rela M, Heaton N, Mieli-Vergani G, Dhawan A (2008) Long-term outcome of mycophenolate rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients. Liver Transplant 14:1303–1308
Balakrishnan K, Pandey A (1996) Influence of amino acids on the biosynthesis of cyclosporine A by Tolypocladium inflatum. Appl Microbiol Biotechnol 45:800–803
Banfi L, Beretta G, Colombo L, Gennari C, Scolastico C (1982) Total synthesis of (+)-thermozymocidin (myriocin) from D-fructose. J Chem Soc Chem Commun 488–490
Bartman CD, Doerfler DL, Bird BA, Remaley AT, Peace JN, Campbell IM (1981) Mycophenolic acid production by Penicillium brevicompactum on solid media. Appl Env Microbiol 41:729–736
Bedford CT, Knittel P, Money T, Phillips GT, Salisbury P (1973) Biosynthesis of mycophenolic acid. Can J Chem 51:694–697
Benedetti A, Colombo E, Nichele M, Pagani H (2002) Process for producing mizoribine by Eupenicillium javanicum. Patent EP 19990103099
Bentley R (2000) Mycophenolic acid: a one hundred year odyssey from antibiotic to immunosuppressant. Chem Rev 100:3801–3825
Birch AJ, English RJ, Massy-Westropp RA, Smith H (1958) Studies in relation to biosynthesis. Part XIV. The origin of the nuclear methyl groups in mycophenolic acid. J Chem Soc 1958:365–368
Birkinshaw JH, Raistrick H, Ross DJ (1952) The molecular constitution of mycophenolic acid, A metabolic product of Penicilliusm brevicompactum Dierckx. Part 3. Further observations on the structural formula for mycophenolic acid. Biochem J 50:630–634
Bissett J (1983) Notes on Tolypocladium and related genera. Can J Bot 61:1311–1329
Boiteau J-G, Van de Weghe P, Eustache J (2001) A new, ring closing metathesis-based synthesis of (–)-fumagillol. Org Lett 3:2737–2740
Borchers AT, Keen CL, Gerhwin ME (2004) Mushrooms, tumors, and immunity: an update. Exp Biol Med 229:393–406
Budde K, Giessing M, Liefeldt L, Neumayer H-H, Glander P (2006) Moderne immunsuppressiva nach Nierentransplantation. Standard oder maßgeschneidert? Urologe 45:9–17
Butch AW (2008) Immunosuppressive drugs. In: Dasgupta A (ed) Handbook of drug monitoring methods. Humana, Totowa, pp 165–199
Carson CA, Kerr MA (2009) Total synthesis of FR901483. Org Lett 11:777–779
Carter SB, Franklin TJ, Jones DF, Leonard BJ, Mills SD, Turner RW, Turner WB (1969) Mycophenolic acid: An anti-cancer compound with unusual properties. Nature 223:848–850
Cattran DC, Wang MM, Appel G, Matalon A, Briggs W (2004) Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol 62:405–411
Chang H-H, Sheu F (2007) A novel fungal immunomodulatory protein (PCP) isolated from Poria cocos activates mouse peritoneal macrophage involved in toll-like receptor 4. FASEB J 21:702.15
Chen L, Gao G, Felczak K, Bonnac L, Patterson SE, Wilson D, Bennett EM, Jayaram HN, Hedstrom L, Pankiewicz KW (2007) Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues. J Med Chem 50:5743–5751
Chen L, Wilson DJ, Labello NP, Jayaram HN, Pankiewicz KW (2008) Mycophenolic acid analoges with a modified metabolic profile. Bioorg Med Chem 16:9340–9345
Chen T-C, Wang T-S (2007) Use of fungal immunomodulatory protein. Patent EP 20060017781
Chihara G (1992) Immunopharmacology of lentinan, a polysaccharide isolated from Lentinus edodes: Its application as a host defense potentiator. Int J Orient Med 17:57–77
Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F (1970a) Antitumour polysaccharide derived chemically from natural glucan (pachyman). Nature 225:934–944
Chihara G, Hamuro J, Maeda YY, Arai Y, Fukuoka F (1970b) Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes. Cancer Res 30:2776–2782
Chun GT, Agathos SN (1989) Immobilization of Tolypocladium inflatum spores into porous celite beads for cyclosporine production. J Biotechnol 9:237–254
Cline JC, Nelson JD, Gerzon K, Williams RH, Delong DC (1969) In vitro antiviral activity of mycophenolic acid and its reversal by guanine compounds. Appl Microbiol 18:14–20
Clutterbuck PW, Oxford AE, Raistrick H, Smith G (1932) Studies in the biochemistry of micro-organisms: the metabolite products of the Penicillium brevicompactum series. Biochem J 26:1441–1485
Contreas M, DeSilva M (1994) The prevention and management of the hemolytic disease of newborn. J R Soc Med 87:256–258
Covarrubias-Zúñiga A, González-Lucas A (1998) A total synthesis of mycophenolic acid. Tetrahedron Lett 39:2881–2882
Covarrubias-Zúñiga A, Gonzalez-Lucas A, Domínguez MM (2003) Total synthesis of mycophenolic acid. Tetrahedron 59:1989–1994
Cui FJ, Chisti Y (2003) Polysaccharopeptides of Coriolus versicolor: physiological activity, uses and production. Biotechnol Adv 21:109–122
Cui FJ, Li Y, Xu ZH, Sun K, Tao WY (2006) Optimization of the medium composition for production of mycelia biomass and exo-polymer by Grifola frondosa GF9801 using response surface methodology. Bioresour Technol 97:1209–1216
Cun Z, Mizuno T, Ito H, Shimura K, Sumiya T, Kawade M (1994) Antitumor activity and immunological property of polysaccharides from the mycelium of liquid-cultures Grifola frondosa. J Jpn Soc Food Sci Technol 41:724–733
Dittmann J, Wenger RM, Kleinkauf H, Lawen A (1994) Mechanism of cyclosporine A biosynthesis. Evidence for biosynthesis via a single linear undecapeptide precursor. J Biol Chem 269:2841–2846
Doerfler DL, Nultron CP, Bartman CD, Gottlieb FJ, Campbell IM (1978) Spore germination, colony development, and secondary metabolism in Penicillium brevicompactum: a radiogas chromatographic and morphological study. Can J Microbiol 24:1490–1501
Doerfler DL, Bartman CD, Campbell IM (1979) Mycophenolic acid production by Penicillium brevicompacturm in two media. Can J Microbiol 25:940–943
Dreyfuss MM, Gams W (1994) Proposal to reject Pachybasium niveum Rostr. In order to retain the name Tolypocladium inflatum W. Gams for fungus that produces cyclosporin. Taxon 43:660–661
El-Araby ME, Bernacki RJ, Makara GM, Pera PJ, Anderson WK (2004) Synthesis, molecular modeling, and evaluation of nonphenolic indole analogs of mycophenolic acid. Bioorg Med Chem 12:2867–2879
El Enshasy H (2007) Filamentous fungal cultures – process characteristics, products, and applications. In: Yang ST (ed) Bioprocessing for value-added products from renewable resources. Elsevier, Rotterdam, pp 225–261
El Enshasy H, Abdel Fattah Y, Atta A, Anwar M, Omar H, Abou EL Magd S, Abou Zahra R (2008) Kinetics of cell growth and cyclosporine A production by Tolypocladium inflatum when scaling up from shake flask to bioreactor. J Microbiol Biotechnol 18:913–917
Engel G, von Milczewski EE, Prokopek D, Teuber M (1982) Strain-specific synthesis of mycophenolic acid by P. roqueforti in blue-veined cheese. Appl Env Microbiol 43:1034–1040
Epinette WW, Parker CM, Jones EI, Greist MC (1987) Mycophenolic acid for psoriasis. J Am Acad Dermatol 17:962–971
Eugui EM, Allison AC (1993) Immunosuppressive activity of mycophenolic mofetil. Ann NY Acad Sci 685:309–329
Falch BH, Espevik T, Ryan L, Stokke BT (2000) The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation. Carbohydr Res 329:587–596
Fan L, Soccol CR, Pandey A (2008) Mushroom production. In: Pandey A, Soccol CR, Larroche C (eds) Current developments in solid-state fermentation. Springer Science+Business Media, New York, pp 253–274
Ferraresso M, Kahan BD (1993) New immunosuppressive agents for pediatric transplantation. Pediatr Nephrol 7:567–573
Figg WD, Pluda JM, Lush RM, Saville MW, Wyvill K, Reed E, Yarchoan R (1997) The pharmacokinetics of TNP-470, a new angiogenesis inhibitor. Pharmacotherapy 17:91–97
Foster BC, Coutts RT, Pasutto FM, Dossetor JB (1983) Production of cyclosporin A by carrageenan-immobilized Tolypocladium inflatum in an airlift reactor with external loop. Biotechnol Lett 5:693–696
Fuji K, Fujita E, Takaishi Y, Fujita T, Arita I, Komatsu M, Hirasuki N (1978) New antibiotics, trichopolyns A and B: isolation and biological activity. Experientia 34:237–239
Fujimoto H, Nakayama Y, Yamazaki M (1993) Identification of immunosuppressive components of musrhoom, Lactarius flavidulus. Chem Pharm Bull 41:654–658
Fujimoto H, Satoh Y, Yamazaki M (1998) Four new immunosuppressive components, kobiin and kobifuranones A, B, and C, from an ascomycetes, Gelasinospora kobi. Chem Pharm Bull 46:211–216
Fujino M, Li XK, Kitazawa Y, Guo L, Kawasaki M, Funeshima N, Amano T, Suzuki S (2002) Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-fas antibody in human T-lymphoma cell line (Jurkat cells). Pharmacol Exp Therap 300:939–945
Fujita T, Takaishi Y, Okamura A, Fujita E, Fuji K, Hirasuka N, Momatsu M, Arita I (1981) New peptide antibiotics, tricopolyns I and II from Trichoderma polysporum. J Chem Soc Chem Commun 585–587
Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R, Chiba K, Hoshino Y, Kumoto T (1994) Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot 47:208–215
Fujita T, Hamamichi N, Kiuchi M, Matsuzaki T, Kito Y, Inoue K, Hirose R, Yoneta M, Sasaki S, Chiba K (1996) Determination of absolute configuration and biological activity of new immunosuppresants, mycestericins D, E, F and G. J Antibiot 49:846–853
Gams W (1971) Tolypocladium. Eine Hyphomycetengattung mit geschwollenen Philaliden. Persoonia 6:185–191
Gao Y, Zhou S (2003) Cancer prevention and treatment by Ganoderma, a mushroom with medicinal properties. Food Rev Int 19:275–325
Gao Y, Zhou S, Chen G, Dai X, Ye J (2003) A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. Extract (ganopoly) in patients with advanced cancer. Int J Med Mushroom 4:207–214
Gong HG, Zhong JJ (2005) Hydrodynamic shear stress affects cell growth and metabolite production by medicinal mushroom Ganoderma lucidum. Chin J Chem Eng 13:426–428
Gregory CR, Kyles AE, Bernsteen L, Wagner GS, Tarantal AF, Christe KL, Brignolo L, Spinner AG, Griffey SM, Paniagua RT, Hubble RW, Borie DC, Morris RE (2004) Compared with cyclosporine, ISATX247 significantly prolongs renal-allograft survival in a nonhuman primate model. Transplantation 78:681–685
Gullo VP, McAlpine J, Lam KS, Baker W, Petersen F (2006) Drug discovery from natural products. J Ind Microbiol Biotechnol 33:523–531
Hartmann N, Enk A (2005) Mycophenolate mofetil and skin diseases. Lupus 14 [Suppl 1]:S58–S63
Hatanaka H, Kino T, Hashimoto M, Tsurumi Y, Kuroda A, Tanaka H, Goto T, Okuhara M (1988) FR65814, a novel immunosuppressant isolated from a Penicillium strain. J Antibiot 41:999–1008
Hayashi M, Kim YP, Takamatsu S, Preeprame S, Komiya T, Masuma R, Tanaka H, Komiyama K, Omura S (1996) Chlovalicin, a new cytocidal antibiotic produced by Sporothrix sp. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot 49:631–634
Hiestand, PC, Gunn H, Gale J (1985) The immunosuppressive profile of a new natural cyclosporine analogue: Nva2-cyclosporine. Transplant Proc 17:1362–1364
Hiestand PC, Graber M, Hurtenbach V, Hermann P, Borel JF (1992) The new cyclosporine derivative, SDZ IMM 125: in vitro and in vivo pharmacological effects. Transplant Proc 24:31–38
Hobbs C (2000) Medicinal values of Lentinus edodes (Berk.) Sing. (Agaricomyvetideae). A literature review. Int J Med Mushrooms 2:287–297
Hodge KT, Krasnoff SB, Humber RA (1996) “Tolypocladium inflatum is the anamorph of Cordyceps subsessilis”. Mycologia 88:715–719
Hoffmann K, Schneider-Scherzer E, Klein-Kauf H, Zocher R (1994) Purification and characterization of an eukaryotic alanine racemas, acting as a key enzyme in cyclosporine biosynthesis. J Biol Chem 269:12710–12714
Hood KA, Zarembski DG (1997) Mycophenolate mofetil: a unique immunosuppressive agent. Am J Health Sys Pharm 54:285–294
Hoppert M, Gentzsch C, Schörgendorfer K (2001) Structure and localization of cyclosporine synthetase, the key enzyme of cyclosporine biosynthesis in Tolypocladium inflatum. Arch Microbiol 176:285–293
Hsiao Y-M, Huang Y-L, Tang S-C, Shieh G-J, Lai J-Y, Wang H, Ying T-H, Ko J-L (2008) Effect of a fungal immunomodulatory protein from Ganoderma tsugae on cell cycle and interferon-gamma production through phosphatidylinositol 3-kinase signal pathway. Process Biochem 43:423–430
Hsu H-C, Hsu C-I, Lin R-H, Kao C-L, Lin J-Y (1997) Fip-vvo, a new fungal immunomodulatory protein isolated from Volvariella volvacea. Biochem J 323:557–565
Iaccarino L, Rampudda M, Canova M, Della Libera S, Sarzi-Puttinic P, Doria A (2007) Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev 6:190–195
Iijima M, Masuda T, Nakamura H, Naganawa H, Kurasawa S, Okami Y, Ishizuka M, Takenchi T, Itaka Y (1992) Metacytofilin, a novel immunomodulator produced by Metarhizium sp. TA2759. J Antibiot 45:1553–1556
Ikekawa T, Uehara N, Maeda Y, Nakanish M, Fukuoka F (1969) Antitumor activity of aqueous extracts of edible mushrooms. Cancer Res 29:734–735
Im D-S (2003) Linking Chinese medicine and G-protein-coupled receptors. Trends Pharmacol Sci 24:2–4
Iwabuchi Y, Furukawa M, Esumi T, Hatakeyama S (2001) An enantio- and stereocontrolled synthesis of (–)-mycestericin E via cimchona alkaloid-catalyzed asymmetric Baylis–Hillman reaction. Chem Comm (Comb) 19:2030–2031
Jaureguiberry G, Farragia-Fougerouse G, Audier H, Lederer E (1964) On transfer of the CD-3 group of methionine-CD-3 during biosynthesis of mycophenolic acid. CR Acad Sci Paris 259:3108–3110
Jekkel A, Barta I, Kónya A, Sütő J, Boros S, Horváth G, Ambrus G (2001) Microbiological transformation of mycophenolic acid. J Mol Cat B Enz 11:423–426
Jekkel A, Barta I, Boros S, Sütő J, Horváth G, Szabó Z, Ambrus G (2002) Microbiological transformation of mycophenolic acid. Part II. J Mol Cat B Enz 19/20:209–214
Jones MC, Marsden SP (2008) Total synthesis of the immunosuppressants myriocin and 2-epi-myriocin. Org Lett 10:4125–4128
Jorgensen KA, Koefoed-Nielsen PB, Karamperis N (2003) Clacineurin phosphate activity and immunosuppression. A review on the role of calcineurin phosphate activity and the immunosppressive effect of cyclosporin A and tacrolimus. Scand J Immunol 57:93–98
Kahan BD (1992) New immunosuppressive drugs: needs in an applications to pediatric transplantation. Eur J Pediatr 151[Suppl 1]:S9–S12
Kallen J, Mikol V, Quesniaux VFJ, Walkinshaw MD, Schneider-Scherzer E, Schörgendorfer K, Weber G, Fliri HG (1997) Cyclosporins: Recent developments in biosynthesis, pharmacology and biology, and clinical applications. In: Rehm, H-J. and Reed G (eds) Biotechnology, VCH, Weinheim, pp 535–591
Kamigauchi T, Sakazaki R, Nagashima K, Kawamura Y, Yasuda Y, Matsushima K, Tani H, Takahashi Y, Ishii K, Suzuki R, Koizumi K, Nakai H, Ikenishi Y, Terui Y (1998) Terprenin, novel immunosuppressants produced by Aspergillus candidus. J Antibiot 51:445–450
Kawada K, Arimura K, Tsuri T, Fuji M, Komurasaki T, Yonezawa S, Kugimiya A, Haga N, Mitsumori S, Inagaki M, Nakatani T, Tamura Y, Takechi S, Taishi T, Kishino J, Ohtani M (1998) Total synthesis of terprenin, a highly potent and novel immunoglobulin E antibody suppressant. Ang Chem Int Ed 37:973–975
Kawagishi H, Nomura A, Mizuno T, Kimura A, Chiba S (1990) Isolation and characterization of lectin from Grifola frondosa fruiting bodies. Biochim Biophys Acta 1034:247–252
Khan MM (2008) Immunosuppressive agents. In: Khan MM (ed) Immunopharmacology Springer Science+Business Media, New York, pp 87–105
Khedkar AP, Subramaniyam P, Ananda K, Ramkrishna M, Tambe SP, Ganesh S, Sircar A, Shrikumar S (2007) Manufacture and purification of cyclosporine A. US Patent 7,176,001
Kida T, Takehiko I, Hiroshiro S (1984) Method for production of mycophenolic acid by fermentation. US Patent 4,452,891
Kim D, Ahn SK, Bae H, Choi WJ, Kim HS (1997) An asymmetric total synthesis of (–)-fumagillol. Tetrahedron Lett 38:4437–4440
Kim D, Ahn SK, Bae H, Kim HS (2005a) A stereoselective asymmetric synthesis of antibiotic (–)-fumagillol using claisen rearrangement and intramolecular ester enolate alkylation as key steps. Arch Pharm Res 28:129–141
Kim F, Sakagami H, Tanuma SI, Konno K (1990) Stimulation of interferon-γ-induced human myelogenous leukemic cell differentiation by high molecular weight PSK subfraction. Anticancer Res 10:55–58
Kim HM, Paik SY, Ra KS, Koo KB, Yun JW, Choi JW (2006) Enhanced production of exopolysaccharides by fed-batch culture of Ganoderma resinaceum DG-6556. J Microbiol 44:233–242
Kim YO, Han SB, Lee HW, Ahn HJ, Yoon YD, Jung JK, Kim HM, Shin CS (2005b) Immuno-stimulating effect of the endo-polysaccharide produced by submerged culture of Inonotus obliquus. Life Sci 77:2438–2456
Kino K, Yamashita A, Yamaoka K, Watanabe J, Tanaka S, Ko K, Shimizu K, Tsunoo H (1989) Isolation and characterization of a new immunomodulatory protein, Ling Zhi-8 (LZ-8), from Ganoderma lucidium. J Biol Chem 264:472–478
Klatt J, Hartung H-P, Hohlfeld R (2007) FTY720 (Fingolimod) als neue Therapiemöglichkeit der Multiplen Sklerose. Nervenarzt 78:1200–1208
Kluepfel D, Bagli J, Baker H, Charest M-P, Kudelski A, Sehgal SN, Vézina C (1972) Myriocin, a new antifungal antibiotic from Myriococcum albomyces. J Antibiot 25:109–115
Kluepfel D, Kudelski A, Bagli J (1975) Myriocin and process of preparation. US Patent 3,928,572
Ko JL, Hsu CI, Lin RH, Kao CL, Lin JY (1995) A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes and its complete amino acid sequence. Eur J Biochem 228:244–249
Kratochvil B, Jegorov A, Pakhomova S, Husák M, Bulej P, Cvak L, Sedmera P, Havlicek V (1999) Crystal structure of cyclosporine derivatives: O-acetyl-(4R)-4-(E-2-butyl)-4,N-dimethyl-L-threonyl-cyclosporin A and O-acetyl-(4R)-4-[E-2-(4-bromobutyl)]-4,N-dimethyl-L-threonyl-cyclosporin A. Collect Czec Chem Commun 64:89–98
Krishna C (2005) Solid-state fermentation systems – an overview. Crit Rev Biotechnol 25:1–30
Kroll M, Arenzana-Seisdedos F, Bachelerie F, Thomas D, Fringuet B, Conconi M (1999) The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem Biol 6:689–698
Kropf JF, Meigh IC, Bebbington MWP, Weinreb SM (2006) Studies on a total synthesis of the microbial immunosuppressive agent FR901483. J Org Chem 71:2046–2055
Kuboki H, Tsuchida T, Wakazono K, Isshik K, Kumagai H, Yoshioka T (1999) Mer-f3, 12-hydroxy-ovalicin, produced by Metarhizium sp. F3. J Antibiot 52:590–593
Kupfahl C, Ruppert T, Dietz A, Geginat G, Hof H (2007) Candida species fail to produce the immunosuppressive secondary metabolite gliotoxin in vitro. FEMS Yeast Res 7:986–992
Lafont P, Debeaupuis JP, Gaillardin M, Payen J (1979) Production of mycophenolic acid by Penicillium roqueforti strains. Appl Env Microbiol 37:365–368
Lawen A, Zocher R (1990) Cyclosporin synthetase. The most complex peptide synthesizing multienzyme polypeptide so far described. J Biol Chem 256:11355–11360
Lee J, Agathos SN (1989) Effect of amino acids on the production of cyclosporine A by Tolypocladium inflatum. Biotechnol Lett 11:77–82
Lee TH, Chun G-T, Chang YK (1997) Development of sporulation/immobilization method and its application for the continuous production of cyclosporin A by Tolypocladium inflatum. Biotechnol Prog 13:548–550
Lee WA, Gu L, Miksztal AR, Chu N, Leung K, Nelson PH (1990) Bioavailability improvement of mycophenolic acid through amino ester derivatization. Pharm Res 7:161–166
Leung MY, Fung KP, Choy YM (1997) The isolation and characterization of an immunomodulatory and antitumor polysaccharide preparation from Flammulina velutipers. Immunopharmacol 35:255–263
Leung MYK, Liu C, Koon JCM, Fung KP (2006) Polysaccharide biological response modifiers. Immunol Lett 105:101–114
Licastro F, Morini MC, Kretz O, Dirheimer G, Creppy EE, Stirpe F (1993) Mitogenic activity and immunological properties of bolesatine, a lectin isolated from the mushroom Boletus satanas Lenz. Int J Biochem 25:789–792
Lida A, Mihara T, Fujita T, Takaishi Y (1999) Peptidic immunosuppressants from the fungus Trichoderma polysporum. Bioorg Med Chem Lett 24:3393–3396
Lim JM, Yun JW (2006) Enhanced production of exopolysaccharides by supplementation of toluene in submerged culture of an edible mushroom Collybia maculate TG-1. Process Biochem 41:1620–1626
Lin WH, Hung CH, Hsu CI, Lin JY (1997) Dimerization of the N-terminal amphipathic alpha-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae (Fip-gts) defined by yeast two hybrid system and site-directed mutagenesis. J Biol Chem 272:20044–20048
Lindequist U, Niedermeyer THJ, Jülich W-D (2005) The pharmaceutical potential of mushrooms. eCAM 2:285–299
Liu C, Xie H, Su H, Han J, Liu Y (2003) Anti-thrombus effect on the fermented products of mycelium from Tremella aurantialba. Nat Prod Res Dev 3:35–37
Liu F, Ooi VEC, Liu WK, Chang ST (1996) Immunomodulation and antitumor activity of polysaccharide–protein complex from culture filtrate of a local edible mushroom, Tricholoma lobayense. Gen Pharmacol 27:621–624
Liu J-K (2006) Natural terphenyls: developments since 1877. Chem Rev 106:2209–2223
Liu S, Widom J, Kemp CW, Crews CM, Clardy J (1998) Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science 282:1324–1327
Liu V, Mackool BT (2003) Mycophenolate in dermatology. J Dermatol Treat 14:203–211
Logothetis CJ, Wu KK, Finn LD, Daliani D, Figg W, Ghaddar H, Gutterman JU (2001) Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. Clin Cancer Res 7:1198–1203
Loosli HR, Oschkinat H, Weber HP, Petcher T (1985) The conformation of cyclosporine A in the crystal and in solution. Helv Chim Acta 69:682–704
Lowe E, Rice P, Ha TZ, Li CF, Kelley J, Ensley H, Lopez-Perez J, Kalbfleisch J, Lowman D, Margl P, Browder W, Williams D (2001) A (1→3)-β-D-linked heptasaccharide is the unit ligand for glucose pattern recognition receptors on human monocytes. Microbes Infect 3:789–797
Lull C, Wichers HJ, Savelkoul HFJ (2005) Antiinflammatory and immunomodulating properties of fungal metabolites. Mediat Inflam 2:63–80
Ly M, Margaritis A (2007) Effect of temperature on the extraction kinetics and diffusivity of cyclosporine A in the fungus Tolypocladium inflatum. Biotechnol Bioeng 96:945–955
Ly M, Margaritis A, Jajuee B (2007) Effect of solvent concentration on the extraction kinetics and diffusivity of cyclosporine A in the fungus. Tolypocladium inflatum. Biotechnol Bioeng 96:67–79
Mao XB, Zhong JJ (2004) Hyperproduction of corydycepin by two-stage dissolved oxygen control in submerged cultivation of medicinal mushroom Cordyceps militaris in bioreactors. Biotechnol Prog 20:1408–1413
Mao XB, Zhong JJ (2006) Significant effect of NH4 + on cordycepin production by submerged cultivation of medicinal mushroom Cordyceps militaris. Enz Microb Technol 38:343–350
Marahiel MA, Stachelhaus T, Mootz HD (1997) Modular peptide synthetases involved in non-ribosomal synthesis. Chem Rev 97:2651–2673
Matsuzawa Y, Nakase T (1984) Metabolite fate of ethyl O-[N-(p-carboxyphenyl)-carbamoyl] mycophenolate (CAM), a new antitumor agent, in experimental animals. J Pharmacobiodyn 7:776–783
Mazitschek R, Huwe A, Giannis A (2005) Synthesis and biological evaluation of novel fumagillin and ovalicin analogues. Org Biomol Chem 3:2150–2154
McCorkindale NJ Baxter RL (1981) 4-methyl- and 7-methylphthalan-1-one derivatives of mycophenolic acid: use in establishing the distribution of acetate derived hydrogens. Tetrahedron 37:2131–2136
Menza-Aviña ME, Ordoñez M, Fernández-Zertuche M, Rodriguez-Fragoso L, Esparza JR, de los Ríos-Corsino AAM (2005) Synthesis of some monocyclic analogues of mycophenolic acid via the Johnson ortho ester Claisen rearrangement. Bioorg Med Chem 13:6521–6528
Mi-Jin L, Duong CTP, Han K, Kim E-S (2009) Combination strategy to increase cyclosporin A productivity by Tolypocladium niveum using random mutagenesis and protoplast transformation. J Microbiol Biotechnol 19:869–872. doi: 10.4014/jmb.0811.629
Mimura H, Ohno N, Suzuki I, Yadomae T (1985). Purification, antitumor activity, and structural characterization of β-1,3-glucan from Peziza versiculosa. Chem Pharm Bull 33:5096–5099
Mitsui H, Matsuno T, Ogawa H, Shiio T, Yugari Y, Tamura G (1981) Antitumor activity of a new compound, ethyl O-[N-(p-carboxyphenyl)-carbamoyl]-mycophenolate, against various experimental tumors upon oral administration. Gann 72:66–71
Miyake Y, Kozutsumi Y, Nakamura S, Fujita T, Kawasaki T (1995) Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun 211:396–403
Miyazaki T, Nishijima M (1981) Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull 29:3611–3625
Mizobuchi M, Iwasaki Y, Sako K, Kaneko Y (1997) Suppression of acute experimental allergic encephalomyelitis in Lewis rats with a mycophenolic acid derivative. Tohoku J Exp Med 182:217–229
Mizuno K, Tsujino M, Takada M, Hayashi M, Atsumi K, Asano K, Matsuda T (1974) Studies on bredinin, I. Isolation, characterization and biological properties. J Antibiot 27:775–782
Mizuno K, Takuji A, Masatoshi T, Masaki T, Munetoshi Y, Tetsuo M, Mitsuo H (1975) 4-Carbamoyl-1-β-D-ribofuranosylimidazolium-5-olate. US Patent 3,888,843
Mizuno T (1992) Antitumor active polysaccharides isolated from the fruiting body of Hericium erinaceum, and edible, and medicinal mushroom called Yamabushitake or Houtou. Biosci Biotechnol Biochem 56:349–357
Molino BF, Yang Z (2006) Novel cyclosporine analogues and their pharmaceutical uses. US Patent 2006/0069015 A1
Moradali M-F, Mostafavi H, Chods S, Hedjaroude G-A (2007) Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int Immunopharmacol 7:701–724
Moussaïf M, Jacques P, Schaarwächter P, Budzikiewicz H, Thonart P (1997) Cyclosporin C is the main antifungal compound produced by Acremonium luzulae. Appl Environ Microbiol 63:1739–1743
Muth WL, Nash III CH (1975) Biosynthesis of mycophenolic acid: purification and characterization of S-adenosyl-L-methionine: Demethylmycophenolic acid O-methyltransferase. Antimicrob Agents Chemother 8:321–327
Mydlarski PR (2005) Mycophenolate mofetil: a dermatologic perspective. Skin Ther Lett 10:1–6
Nakajima S, Nozawa K (1979) Isolation in high yield citrinin from Penicillium odoratum and of mycophenolic acid from Penicillium brunneostoloniferum. J Nat Prod 42:423–426
Nakajima H, Hasasaki T, Tanaka K, Kimura Y, Udagawa S-I, Horie Y (1989) Production of cyclosporine by fungi belonging to the genus Neocosmospora. Agric Biol Chem 53:2291–2292
Nawata Y, Kuriki Y, Haneda M, Ochi K, Mori T (1988) Structure of a mycophenolic acid derivative (CAM). Acta Cryst C44:196–198
Nawata Y, Kuriki Y, Haneda M, Ochi K, Mori T (1989) Crystal structure of a mycophenolic acid derivative, CAM (form Ia). Anal Sci 5:119–120
Nelson PH, Eugul E, Wang CC, Allison AC (1990) Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid. J Med Chem 33:833–838
Nelson PH, Carr SF, Devens BH, Eugui EM, Franco F, Gonzalez C, Hawley RC, Loughhead DG, Milan DJ, Papp E, Patterson JW, Rouhafza S, Sjogren EB, Smith DB, Stephenson RA, Talamas FX, Waltos A-M, Weikert RJ, Wu JC (1996) Structure–activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acid. J Med Chem 39:4181–4196
Niido O, Suzuki Y, Yoshimaru T, Inoue T, Takayama T, Ra C (2006) Fungal metabolite gliotoxin blocks mast cell activation by a calcium- and superoxide-dependent mechanism: implications of immunosuppressive activities. Clin Immunol 118:108–116
Nulton CP, Campbell IM (1977) Mycophenolic acid is produced during balanced growth of Penicillium brevicompactum. Can J Microbiol 23:20–27
Nulton CP, Campbell IM (1978) Labelled acetone and levulinic acid are formed when [14C]acetate is being converted to mycophenolic acid in Penicillium brevicompactum. Can J Microbiol 24:1999–2001
Offenzeller M, Su Z, Santer G, Moser H, Traber R, Memmert K, Schneider-Scherzer E (1993) Biosynthesis of the unusual amino acid (4R)-4-[(E)-2-butenyl]-4-methyl-L-threonine of cyclosporine A. Identification of 3(R)-hydroxy-4(R)-methyl-6(E)-octenoic acid as a key intermediate by enzymatic in vitro synthesis and by in vivo labelling techniques. J Biol Chem 268:26127–26134
Ohno N, Miura NN, Chiba N, Adachi Y, Yadomae T (1995) Conparison of the immunopharmacological activities of triple and single-helical schizophyllan in mice. Biol Pharmaceut Bull 18:1242–1247
Oishi T, Ando K, Inomiya K, Sato H, Iida M, Chida N (2002) Total synthesis of (+)-myriocin and (–)-sphingofungin E from aldohexoses using overman rearrangement as the key reaction. Bull Chem Soc Jpn 75:1927–1947
Ooi VEC (2008) Antitumor and immunomodulatory activities of mushroom polysaccharides. In: Cheung PCK (ed) Mushrooms as functional food. Wiley, Singapore, pp 147–198
Ooi VEC, Liu F (2000) Immunomodulation and anti-cancer activity of polysaccharide-protein complex. Curr Med Chem 7:715–729
Ozaki H, Ishihara M, Kida T, Yamanaka S, Shibai H (1987a) Mycophenolic acid production by drug-resistant and methionine or glutamic-acid requiring mutants of Penicillium brevicompactum. Agric Biol Chem 51:2509–2514
Ozaki H, Kubota K, Takahashi H (1987b) Effects various adsorbents on mycelium formation and mycophenolic acid production by Penicillium brevicompactum. Agric Biol Chem 51:2503–2508
Pahl HL, Krauβ B, Schulze-Osthoff K, Decker T, Traenckner EBM, Vogt M, Myers C, Parks T, Warring P, Mühlbacher A, Czernilofsky A-P, Baeuerle PA (1996) The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J Exp Med 183:1829–1840
Palleschi A, Bocchinfuso G, Coviello T, Alhaique F (2005) Molecular dynamics investigations of the polysaccharide sclera-glucan: first study on the triple helix structure. Carbohydr Res 340:2154–2162
Patel J, Kobashigawa JA (2008) Minimization of immunosuppression transplant immunology. Transplant Immunol 20:38–54
Patterson JW (1993) The synthesis of mycophenolic acid. Tetrahedron 49:4789–4798
Pirofski L-A, Casadevall A (2006). Immunomodulators as an antimicrobial tool. Curr Opin Microbiol 9:489–495
Plé PA, Hamon A, Jones, G (1997) A convergent synthesis of mycophenolic acid. Tetrahedron 53:3395–3400
Preddie DC, Markowitz GS, Radhakrishnan J, Nickolas TL, D’Agati VD, Schwimmer JA, Gardenswartz M, Rosen R, Appel GB (2006) Mycophenolate mofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol 1:718–722
Puel O, Tadrist S, Galtier P, Oswald I, Delaforge M (2005) Byssochlamys nivea as a source of mycophenolic acid. Appl Environ Microbiol 71:550–553
Queener SW, Nash III CH (1978) Procedure for obtaining Penicillium species mutants with improved ability to synthesize mycophenolic acid. US Patent 4,115,197
Queener SW, Wilkerson SG, Nash III CH (1982) Sterol content and titer of mycophenolic acid in polyene antibiotic resistant mutants of Penicillium stoloniferum. In: Krumphabzl V, Sikyta B, Vanek Z (eds) Overproduction of microbial products. Academic, New York, pp 535–548
Ren Y, Strobel GA, Graff JC, Jutila M, Park SG, Gosh S, Teplow D, Condron M, Pang E, Hess WM, Moore E (2008) Colutellin A, an immunosuppressive peptide from Colletotrichum dematium. Microbiology 154:1973–1979
Research and Markets (2007) http://www.researchandmarkets.com/reports/573667. Accessed 20 May 2009
Reshetnikov SV, Wasser SP, Tan KK (2001) Higher basidiomycetes as a source of antitumor and immunostimulating polysaccharides. Int J Med Mushrooms 3:361–394
Roh YT (2008) Process for mass production of mycophenolic acid by using urea as nitrogen source. Patent WO 2008/026883 A1
Rohloff JC, Gardner JO, Towne RW (1995) Mycophenolate dianions. Tetrahedron Lett 43:7803–7806
Russell R, Paterson M (2008) Cordyceps – a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 69:1469–1495
Sadhukhan AK, Murthy MVR, Kumar RA, Mohan EVS, Vandana G, Bhar C, Rao KV (1999) Optimization of mycophenolic acid production in solid state fermentation using response surface methodology. J Ind Microbiol 22:33–38
Sakai J-I, Kezuka T, Yokoi H, Okada AA, Usui M, Mizuguchi J, Kaneko Y (1999) Suppressive effects of a novel compound on interphotoreceptor retinoid-binding protein-induced experimental autoimmune uveoretinitis in rats. Allergol Int 48:189–197
Sakamoto K, Tsujii E, Abe F, Nakanishi T, Yamashita M, Shigematsu N, Izumi S, Okuhara M (1996) FR901483, a novel immunosuppressant isolated from Cladobotryum sp. No. 11231. Taxonomy of the producing organism, fermentation, isolation, physico-chemical properties and biological activities. J Antibiot 49:37–44
Sanchis V, Scott PM, Farber JM (1988) Mycotoxin-producing potential of fungi isolated from red kidney beans. Mycopathologia 104:157–162
Sarangi I, Ghosh D, Bhutia SK, Mallick SK, Maiti TK (2006) Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int Immunopharmacol 6:1287–1297
Sasaki S, Hashimoto R, Kiuchi M, Inoue K, Ikumoto T, Hirose R, Chiba K, Hoshino Y, Okumoto T, Fujita T (1994) Fungal metabolites. Part 14. Novel potent immunosuppressants, mycestericins, produced by Mycelia sterilia. J Antibiot 47:420–433
Sasaki T, Takasuka N, Chihara G, Maeda YY (1976) Antitumor activity of degraded products of lentinan – its correlation with molecular weight. Gann 67:191–195
Sato H, Sato K, Iida M, Yamanaka H, Oishi T, Chiba N (2008) Total synthesis of mycestericin A. Tetrahedron Lett 49:1943–1947
Sawada H, Kaihara S, Egawa H, Inomata Y, Tanaka K, Yamaoka Y (1996) Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats. Transplant Proc 28:2512–2513
Sawai K, Okuno T, Terada Y, Harada Y, Sawamura K, Sasaki H, Takao S (1981) Isolation and properties of two antifungal substances from Fusarium solani. Agric Biol Chem 45:1223–1228
Schneweis I, Meyer K, Hörmansdorfer S, Bauer J (2000) Mycophenolic acid in silage. Appl Environ Microbiol 66:3639–3641
Schreiber SL Crabtree GR (1992) The mechanism of action of cyclosporine A and FK-506. Immunol Today 13:1–15
Seidel G, Laurich D, Fürstner A (2004) Iron-catalyzed cross-coupling reactions. A scalable synthesis of the immunosuppressive agent FTY720. J Org Chem 69:3950–3952
Sekar C, Balaraman K (1998a) Immobilization of the fungus, Tolypocladium sp. for the production of cyclosporine A. Bioproc Eng 18:281–283
Sekar C, Balaraman K (1998b) Optimization studies on the production of cyclosporine A by solid state fermentation. Bioproc Eng 18:293–296
Sekar C, Rajasekar VW, Balaraman K (1997) Production of cyclosporine A by solid state fermentation. Bioproc Eng 17:257–259
Senn H, Weber C, Kobel H, Traber R (1991) Selective 13C-labelling of cyclosporine A. Eur J Biochem 199:653–658
She QB, Ng TB, Liu WK (1998) A novel lectin with potent immunomodulatory activity isolated from both fruiting bodies and cultured mycelia of the edible mushroom Volvariella volvacea. Biochem Biophys Res Comm 247:106–116
Shibasaki F, Hallin U, Uchino H (2002) Calcineurin as a multifunctional regulator. J Biochem (Tokyo) 131:1–15
Shumpei Y (2002). Mizoribine: mode of action and effects in clinical use. Pediatrics Int 44:196–198
Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH (1989) A cytosolic binding protein for the immunosuppressant FK506 has peptidylprolyl isomerase activity but is distinct from cyclophilin. Nature 341:755–757
Sigg HP, Weber HP (1968) Isolierung und Strukturaufklärung von Ovalicin. Helv Chim Acta 51:1395–1408
Sintchak MD, Fleming MA, Futer O, Raybuck SA, Chambers SP, Caron PR, Murcko MA, Wilson KP (1996) Structure and mechanism of inosine monophosphate dehydrogenase in complex with immunosuppressant mycophenolic acid. Cell 85:921–930
Sircar A, Suryanarayan S, Khedkar AP, Subramaniyam P, Tamber SP (2005) Manufacture and purification of mycophenolic acid. US Patent 6,927,047
Smith JE, Rowan NJ, Sullivan R (2002) Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities. Biotechnol Lett 24:1839–1845
Spatz S, Rundnicka A, McDonald C (1978) Mycophenolic acid in psoriasis. Br J Dermatol 98:429–434
Sugito K, Koshinaga T, Inoue M, Ikeda T, Hagiwara N, Fukuzawa M (2005) The effect of a novel immunosuppressant, FTY720, in mice without secondary lymphoid organs. Surg Today 35:662–667
Survase SA, Saudagar PS, Bajaj IB, Singhal RS (2007) Scleroglucan: fermentative production, downstream processing and applications. Food Technol Biotechnol 45:107–118
Svarstad H, Bugge HC, Dhillion SS (2000) From Norway to Novartis: cyclosporine from Tolypocladium inflatum in an open access bioprospecting regime. Biodiv Conserv 9:1521–1541
Takahashi A, Kusano G, Ohta T, Nozoe S (1988) The constituents of Lactarius flavidulus Imai. Chem Pharm Bull 36:2366–2370
Takahashi A, Kusano G, Ohta T, Nozoe S (1993) Revised structures of flavidulos, constituents of Lactarius flavidulus Imai, and the structure of flavidulol D. Chem Pharm Bull 41:2032–2033
Takazawa K, Hosoda Y, Bashuda H, Yagita H, Okumura K, Kaneko Y (1995) CAM – a novel immunosuppressive agent. Transplant 59:1723–1727
Takei S (2002) Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis. Pediatr Int 44:205–209
Tanaka E, Inoue E, Kawaguchi Y, Tomatsu T, Yamanaka H, Hara M, Kamatani N (2006) Acceptability and usefuleness of mizoribine in the management of rheumatoid arthritis in methotrexate-refractory patients and elderly patients, based on analysis of data from a large-scale observational cohort study. Mod Rheumatol 16:214–219
Tang YJ, Zhong JJ (2003) Role of oxygen supply in submerged fermentation of Ganoderma lucidum for production of Ganoderma polysaccharide and ganoderic acid. Enz Microb Technol 32:478–484
Tang YJ, Zhu LW, Li HM, Li DS (2007) Submerged culture of mushrooms in bioreactors – challenges, current state-of-the-art, and future prospects. Food Technol Biotechnol 45:221–229
Tao Y, Zhang L, Cheung PCK (2006) Physicochemical properties and antitumor activities of water soluble native and sulfated hyperbranched mushroom polysaccharides. Cabohydr Res 341:2261–2269
Tiwari S, Sathyanathan D, Thomas E, Melarkode R, Ramavana G, Suryanaraya S (2003) Fed batch solid state fermentation for the production of mycophenolic acid. Patent WO/2003/106690
Tönshoff B (2006) Mycophenolsäure nach Nierentransplantation. Nephrologe 1:59–61
Traber R, Loosli HR, Hofmann HR (1982) Isolierung und Strukturermittlung der neuen Cyclosporine E, F, G, H und I. Helv Chem Acta 65:1655–1677
Traber R, Hoffmann H, Lossli HR (1987) Neue Cyclosporine aus Tolypocladium inflatum. Die Cyclosporine K–Z. Helv Chem Acta 70:13–36
Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K (1984) Krestin (PSK).Cancer Treat Rev 11:131–155
Turk BE, Su Z, Liu JO (1998) Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression. Bioorg Med Chem 6:1163–1169
Uchida K, Tominaga Y, Haba T, Katayama A, Matsuoka S, Goto N, Ueki T, Kimata T, Takeda A, Morozumi K, Takagi H, Nakao A (2004) Clinical success of NEORAL absorption profile. Transplant Proc 36[Suppl 2S]:S461–S464
Van der Hem LG, van der Vliet JA, Kino K, Hoitsma AJ, Tax WJM (1996) Ling Zhi-8: A fungal protein with immunomodulatory effects. Transplant Proc 28:958–959
Velkov T, Lawen A (2003) Non-ribosomal peptide synthetases as technological platforms for the synthesis of highly modified peptide bioeffectors – cyclosporin synthetase as a complex example. Biotechnol Annu Rev 9:151–197
Velkov T, Singaretnam LG, Lawen A (2006) An improved purification procedure for cyclosporine synthetase. Protein Express Purific 45:275–287
Vinokurova N, Ivanushkina N, Kochkina G, Arinbasarov M, Ozerskaya S (2005) Production of mycophenolic acid by fungi of genus Penicillium link. Appl Biochem Microbiol 41:83–86
Von Arx JA (1986) Tolypocladium, a synonym of Beauveria. Mycotaxon 25:153–158
Vonderscher J, Meinzer A (1994) Rationale for the development of Sandimmune Neoral. Transplant Proc 26:2925–2927
Wang HX, Liu WK, Ng TB, Ooi VEC, Chang ST (1996) The immunomodulatory and antitumor activities of lectins from mushroom Tricholoma mongolicum. Immunopharmacology 31:205–211
Wang HX, Ng TB, Ooi VEC, Liu WK, Chang ST (1997) Actions of lectins from the mushroom Tricholoma mongolicum on macrophages, splenocytes and life-span in sarcoma-bearing mice. Anticancer Res 17:419–424
Wang HX, Gao J, Ng TB (2000) A new lectin with highly potent antihepatoma and antisarcoma activities from the oyster mushroom Pleurotus ostreatus. Biochem Biophys Res Comm 275:810–816
Wang JC, Hu SH, Liang ZC, Yeh CJ (2005) Optimization for the production of water-soluble polysaccharide from Pleurotus citrinopileatus in submerged culture and its antitumor effect. Appl Microbiol Biotechnol 67:759–766
Wang P-H, Hsu C-I, Tang SC, Huang Y-L, Lin J-Y, Ko J-L (2004) Fungal immunomodulatory protein from Flammulina velutipes induces interferon-γ production through p38 mitogen-activated protein kinase signaling pathway. Agric Food Chem 52:2721–2725
Wang YY, Khoo KH, Chen ST, Lin CC, Wong CH, Lin CH (2002) Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activites. Bioorg Med Chem 10:1057–1062
Ward C, Chilvers ED, Lawson MF, Pryde JG, Fujihara S, Farrow SN, Haslett C, Rossi AG (1999) NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 274:4309–4318
Waring P, Beaver J (1996) Gliotoxin and related epipolythiodioxopiperazines. Gen Pharmacol 27:1311–1316
Wasser SP (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60:258–274
Wasser SP, Weis AL (1999) Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives. Int J Med Mushrooms 1:31–62
Wasser SP, Elisashivili VI, Tan KK (2003) Effects of carbon and nitrogen sources in the medium on Tremella mesenterica Retz.: Fr. (Heterobasidiomycetes) growth and polysaccharide production. Int J Med Mushrooms 5:49–56
Weber G, Leitner E (1994) Disruption of the cyclosporine synthetase gene of Tolypocladium niveum. Curr Gent 26:461–467
Weber G, Schörgendorfer K, Schneider-Scherzer E, Leitner E (1994) The peptide synthetase catalyzing cyclosporine production in Tolypocladium niveum is encoded by a giant 458-kilobase open reading frame. Curr Genet 26:120–125
Xu ZN, Yang S-T (2007) Production of mycophenolic acid by Penicillium brevicompactum immobilized in a rotating fibrous-bed bioreactor. Enz Microb Technol 40:623–628
Yalin W, Ishurd O, Cuirong S, Yuanjiang P (2005) Structure analysis and anti-tumor activity of (1→3)-β-D-glucans (cordyglucans) from the mycelia of Cordyceps sinensis. Planta Medica 71:381–384
Yamada A, Kataoka T, Nagai K (2000) The fungal metabolite gliotoxin: immunosuppressive activity on CTL-mediated cytotoxicity. Immunol Lett 71:27–32
Yang B-K, Gu Y-A, Jeong Y-T, Jeong H, Song C-H (2007) Chemical characteristics and immune-modulating activities of exo-biopolymers produced by Grifola frondosa during submerged fermentation process. Int J Biol Macromol 41:327–333
Yang L, Wang R, Liu J, Tong H, Deng Y, Li Q (2004) The effect of polyporus umbellatus polysaccharide on the immunosuppression property of culture supernatant of S180 cells. Chin J Cell Mol Immunol 20:234–237
Yonezawa S, Komurasaki T, Kawada K, Tsuri T, Fuji M, Kugimiya A, Haga N, Mitsumori S, Inagaki M, Nakatani T, Tamura Y, Takechi S, Taishi T, Ohtani M (1998) Total synthesis of terprenin, a novel immunosuppressive p-terphenyl derivative. J Org Chem 63:5831–5837
Zhang M, Cui SW, Cheung PCK, Wang Q (2007) Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol 18:4–19
Zhang P, Cheung PCK (2002) Evaluation of sulfated Lentinus edodes α-(1→3)-D-glucan as a potential antitumor agent. Biosci Biotechnol Biochem 66:1052–1056
Zhang WY, Wang Y, Hou YY (2004) Effects of Chinese medicinal fungus water extract on tumor metastasis and some parameters of immune function. Int Immunopharmacol 4:461–468
Zhong JJ, Tang YJ (2004) Submerged cultivation of medicinal mushrooms for production of valuable bioactive metabolites. Adv Biochem Eng Biotechnol 87:25–59
Zou X (2006) Fed-batch fermentation for hyperproduction of polysaccharide and ergosterol by medicinal mushroom Agaricus brasiliensis. Process Biochem 41:970–974
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Enshasy, H.E. (2011). Immunomodulators. In: Hofrichter, M. (eds) Industrial Applications. The Mycota, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11458-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-11458-8_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11457-1
Online ISBN: 978-3-642-11458-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)